Skip to main content

Table 3 Relationship between infiltrating growth pattern and other clinicopathological factors

From: Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database

Factors   INFα/β INFγ χ2 P value
Sex male 270 (56) 212 (44) 8.49 <0.01
female 89 (44) 114 (56)
Site lower 240 (53) 210 (47) 4.07 0.25
middle 40 (45) 49 (55)
upper 67 (57) 51 (43)
entire 12 (43) 16 (57)
Age (year) mean (SD) 59.6 (9.9) 56.4 (11.3) 15.36* <0.01
Size (cm) mean (SD) 5.4 (2.2) 5.6 (2.6) 0.62* 0.43
Differentiation well/moderate 164 (80) 40 (20) 91.21 < 0.01
poor 195 (41) 286 (59)
Borrmann type I/II 65 (60) 43 (40) 3.11 0.08
III/IV 294 (51) 283 (49)
Lauren type intestinal 162 (80) 40 (20) 94.59 < 0.01
mixed 14 (67) 7 (33)
diffuse 183 (40) 279 (60)
Depth of invasion dMP 64 (52) 59 (48) 0.01 0.93
SS 295 (53) 267 (47)
Lymphatic/venous invasion - 294 (53) 259 (47) 0.66 0.42
+ 65 (49) 67 (51)
TNM stage N0 (0) 110 (56) 87 (44) 9.48 < 0.05
N1 (1–2) 81 (57) 60 (43)
N2 (3–6) 83 (55) 68 (45)
N3a (7–15) 59 (42) 81 (58)
N3b (>15) 26 (46) 30 (54)
JCGC stage N0 110 (56) 87 (44) 4.66 0.20
N1 116 (56) 93 (44)
N2 119 (48) 127 (52)
>N3 14 (42) 19 (58)
FCCs # negative 55 (56) 44 (44) 7.46 <0.01
  positive 3 (19) 13 (81)   
  1. * Unpaired t-test; # analysis only included 115 patients with intraoperative cytological examination.